Province Key Laboratory of Rehabilitation Medicine, Department of Rehabilitation Medicine, West China Hospital of Sichuan University, Chengdu, China.
Nanotechnology Development Department, National Center for Nanoscience and Technology of China, Beijing, China.
PLoS One. 2020 Apr 16;15(4):e0231244. doi: 10.1371/journal.pone.0231244. eCollection 2020.
Quantifying dose-dependent ultra-early edema and ultrastructural changes in the myocyte after drug delivery is important for the development of new mixed calcium channel blockers (CCBs).
Arterial cannulation was used to measure mean arterial pressure in real time; simultaneously, magnetic resonance imaging proton density mapping was used to quantify edema 5-55 min after the delivery of L-type CCBs, T- and L-type CCBs, and solvent to a spontaneously hypertensive rat model. Transmission electron microscopy was used to show ultrastructural changes in the myocyte.
Analysis of variance showed significant differences among the three groups in mean arterial pressure reduction (F = 246.36, P = 5.75E-25), ultra-early level of edema (ULE) (F = 175.49, P = 5.62E-22), and dose-dependent level of edema (DLE) (F = 199.48, P = 4.28E-23). Compared with the solvent's mean arterial pressure reduction (2.65±6.56±1.64), ULE (1.16±0.09±0.02), and DLE (0.0010±0.0001±0.0000), post hoc tests showed that T- and L-type CCBs had better mean arterial pressure reduction (90.67±11.58±2.90, P = 1.06E-24 vs. 68.34±15.19±3.80, P = 1.76E-12), lower ULE (1.53±0.14±0.04, P = 4.74E-9 vs. 2.08±0.18±0.04, P = 2.68E-22), and lower DLE (0.0025±0.0004±0.0001, P = 1.14E-11 vs. 0.0047±0.0008±0.0002, P = 2.10E-11) than L- type CCBs. Transmission electron microscopy showed that T- and L-type CCBs caused fewer ultrastructural changes in the myocytes after drug delivery than L-type CCBs.
T- and L-type CCBs produced less ultra-early and dose-dependent edema, fewer ultrastructural changes in the myocyte, and a greater antihypertensive effect. Proton density mapping combined with arterial cannulation and transmission electron microscopy allowed for quantification of ultra-early and dose-dependent edema, antihypertensive efficacy, and ultrastructural changes in the myocyte. This is important for the evaluation of induced vasodilatory edema.
定量研究药物输送后肌细胞中与剂量相关的超早期水肿和超微结构变化对于新型混合型钙通道阻滞剂(CCB)的开发非常重要。
通过动脉插管实时测量平均动脉压;同时,采用磁共振成像质子密度图定量测量 L 型 CCB、T 和 L 型 CCB 以及溶剂输送至自发性高血压大鼠模型后 5-55 分钟的水肿程度。采用透射电子显微镜显示肌细胞的超微结构变化。
方差分析显示三组间平均动脉压降低(F=246.36,P=5.75E-25)、超早期水肿水平(ULE)(F=175.49,P=5.62E-22)和剂量依赖性水肿水平(DLE)(F=199.48,P=4.28E-23)存在显著差异。与溶剂的平均动脉压降低(2.65±6.56±1.64)、ULE(1.16±0.09±0.02)和 DLE(0.0010±0.0001±0.0000)相比,L 型 CCB 后的后测检验显示 T-和 L-型 CCB 具有更好的平均动脉压降低(90.67±11.58±2.90,P=1.06E-24 与 68.34±15.19±3.80,P=1.76E-12)、更低的 ULE(1.53±0.14±0.04,P=4.74E-9 与 2.08±0.18±0.04,P=2.68E-22)和更低的 DLE(0.0025±0.0004±0.0001,P=1.14E-11 与 0.0047±0.0008±0.0002,P=2.10E-11)。透射电子显微镜显示 T-和 L-型 CCB 在药物输送后对肌细胞的超微结构变化比 L-型 CCB 更少。
T-和 L-型 CCB 引起的超早期和剂量依赖性水肿更少,肌细胞的超微结构变化更少,降压效果更强。质子密度图结合动脉插管和透射电子显微镜可以定量评估超早期和剂量依赖性水肿、降压效果和肌细胞的超微结构变化。这对于评估诱导性血管扩张性水肿非常重要。